-

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against The Gap, Inc. (GPS)

SAN DIEGO--(BUSINESS WIRE)--The Class: Robbins LLP informs investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired The Gap Inc. (NYSE: GPS) securities between November 24, 2021 and July 11, 2022, for violations of the Securities Exchange Act of 1934. Gap operates as a global apparel retail company.

What Now: Similarly situated shareholders may be eligible to participate in the class action against Gap. Shareholders who want to act as lead plaintiff for the class must file their papers by February 3, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

What is this Case About: The Gap Inc. (GPS) Made False and Misleading Statements Regarding its BODEQUALITY Initiative Implemented in Old Navy Stores

According to the complaint, in the second half of 2021 the Company introduced BODEQUALITY, a size-inclusivity campaign introducing up to size 28 in all Old Navy stores. The Company touted this initiative as one of its key drivers of long-term sustainable growth.

However, defendants failed to disclose that: (1) there were execution missteps in size and assortment at Old Navy related to BODEQUALITY, which were adversely impacting Old Navy’s margins and financial results; and (2) contrary to the Company’s statements, there were inventory risks relating to BODEQUALITY that were actually existing that were adversely affecting the Company’s operations.

On April 21, 2022, the Company announced that the CEO of Old Navy had stepped down. On this news, the price of Gap stock fell $2.57, or 17%, per share to close at $11.72 per share on April 22, 2022. On May 20, 2022, The Wall Street Journal published an article revealing that the Company had improperly managed its inventory of plus size clothing at its Old Navy stores causing material declines in margins and business results. On this news, the Company's stock fell 7%, to close at $10.33 per share on May 23, 2022.

On May 27, 2022, the Company filed with the SEC its 10-Q admitting that execution missteps in size and assortment of inventory at Old Navy adversely impacted the Company's financial results. On this news, the stock price fell almost 5%, to close at $11.03 per share on May 31, 2022.

Finally, on July 11, 2022, the Company announced that its president and CEO was stepping down and resigning from the Board of Directors. On this news, Gap's stock price fell 5%, to close at $8.32 per share on July 12, 2022.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against The Gap Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:GPS

Release Summary
The Gap Inc. (GPS) Made False and Misleading Statements Regarding its BODEQUALITY Initiative Implemented in Old Navy Stores
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Vistagen Therapeutics, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and December 16, 2025. Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. For more information, submit a form, email attorney Aaron Dumas...

Investor Notice: Robbins LLP Informs Investors of the Securities Class Action Against Oracle Corporation

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all persons and/or entities who purchased or otherwise acquired Oracle Corporation (NYSE: ORCL) Senior Notes issued pursuant to the Shelf Registration Statement filed with the SEC on March 15, 2024, and as supplemented on September 25, 2025. Oracle is an Austin, Texas-based company that sells database software, enterprise applications, and cloud infrastructure and hardware. For more information,...

Investor Notice: Robbins LLP Informs Investors of the Smart Digital Group Limited Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Smart Digital Group Limited (NASDAQ: SDM) securities between May 5, 2025 and September 26, 2025. Smart Digital, together with its subsidiaries, provides internet media, business planning and consulting, event planning and execution, and software customization and marketing services in Mainland China and Macau. For more information, submit a fo...
Back to Newsroom